TABLE 1.
Study demographics
|
HIV subtype
|
||||
|---|---|---|---|---|
| B (n=854) | non-B (n=268) | Unknown (n=1236) | Total (n=2358) | |
| Sex | ||||
| Male | 725 (84.9) | 110 (41.0) | 971 (78.6) | 1806 (76.6) |
| Female | 129 (15.1) | 158 (59.0) | 250 (20.2) | 537 (22.8) |
| Unknown | 0 (0) | 0 (0) | 15 (1.2) | 15 (0.6) |
| Age at HIV diagnosis, years, mean ± SD | 36.5±9.8 | 35.5±10.4 | 37.5±9.5 | 36.8±9.7 |
| Unknown | 5 (0.6) | 12 (4.5) | 233 (18.9) | 250 (10.6) |
| Birth region | ||||
| North America | 743 (87.0) | 29 (10.8) | 759 (61.4) | 1531 (64.9) |
| Sub-Saharan Africa | 11 (1.3) | 203 (75.7) | 152 (12.3) | 366 (15.5) |
| Europe | 32 (3.7) | 3 (1.1) | 38 (3.1) | 73 (3.1) |
| Asia/Middle East | 28 (3.3) | 17 (6.3) | 21 (2.5) | 76 (3.2) |
| Latin America | 23 (2.7) | 1 (0.4) | 21 (1.7) | 45 (1.9) |
| Oceania | 5 (0.6) | 0 (0) | 2 (0.2) | 7 (0.3) |
| Unknown | 12 (1.4) | 15 (5.6) | 233 (18.9) | 260 (11.06) |
| Race/ethnicity | ||||
| Caucasian | 636 (74.5) | 23 (8.6) | 636 (51.5) | 1295 (54.9) |
| Black | 17 (2.0) | 208 (77.6) | 158 (12.8) | 383 (16.2) |
| Aboriginal* | 115 (13.5) | 8 (3.0) | 135 (10.9) | 258 (10.9) |
| Hispanic | 21 (2.5) | 0 (0) | 16 (1.3) | 37 (1.6) |
| Other | 49 (5.7) | 21 (7.8) | 43 (3.5) | 113 (4.8) |
| Unknown | 16 (1.9) | 8 (3.0) | 248 (20.1) | 272 (11.5) |
| HIV-acquisition risk factor | ||||
| Heterosexual | 177 (20.7) | 238 (88.8) | 305 (24.7) | 720 (30.5) |
| Men who have sex with men | 476 (55.7) | 7 (2.6) | 451 (36.5) | 934 (39.6) |
| Injection drug users | 138 (16.2) | 3 (1.1) | 183 (14.8) | 324 (13.7) |
| Men who have sex with men and injection drug users | 44 (5.2) | 0 (0) | 50 (4.0) | 94 (4.0) |
| Other | 9 (1.1) | 8 (3.0) | 17 (1.4) | 34 (1.4) |
| Unknown | 10 (1.2) | 12 (4.5) | 230 (18.6) | 252 (10.7) |
Data presented as n (%) unless otherwise indicated.
*
Includes First Nations, Métis and Inuit